An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome

Johnson S., Stojanovic J., Ariceta G., Bitzan M., BEŞBAŞ N., Frieling M., ...Daha Fazla

PEDIATRIC NEPHROLOGY, cilt.29, sa.10, ss.1967-1978, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 10
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s00467-014-2817-4
  • Dergi Adı: PEDIATRIC NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1967-1978
  • Hacettepe Üniversitesi Adresli: Evet

Özet

In 2009, the European Paediatric Study Group for Haemolytic Uraemic Syndrome (HUS) published a clinical practice guideline for the investigation and initial therapy of diarrhea-negative HUS (now more widely referred to as atypical HUS, aHUS). The therapeutic component of the guideline (comprising early, high-volume plasmapheresis) was derived from anecdotal evidence and expert consensus, and the authors committed to auditing outcome.